Ceapro (CVE:CZO) Trading Down 11.8% – Here’s What Happened
by Danessa Lincoln · The Markets DailyCeapro Inc. (CVE:CZO – Get Free Report) fell 11.8% during trading on Monday . The company traded as low as C$0.23 and last traded at C$0.23. 5,850 shares were traded during mid-day trading, a decline of 88% from the average session volume of 50,562 shares. The stock had previously closed at C$0.26.
Ceapro Trading Down 11.8%
The stock has a 50-day moving average of C$0.22 and a 200 day moving average of C$0.23. The company has a quick ratio of 18.88, a current ratio of 7.10 and a debt-to-equity ratio of 8.28. The stock has a market cap of C$688,880.00, a PE ratio of -2.83 and a beta of 1.38.
About Ceapro
Ceapro Inc, a biotechnology company, engages in the development and marketing of health and wellness products and technology relating to plant extracts in the United States, Germany, China, Canada, and internationally. The company is involved in the development of proprietary extraction technologies and the application of these technologies to the production, development, and commercialization of active ingredients, such as oat beta glucan and avenanthramides, which are derived from oats and other renewable plant resources for healthcare and cosmetic industries.
Featured Articles
- Five stocks we like better than Ceapro
- What is Put Option Volume?
- ServiceNow’s $7 Billion Gamble: Panic or Opportunity?
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Dell and HP Are Raising Prices—And Investors Should Take Note
- Stock Average Calculator
- Why DLocal Is the Top Emerging Market Fintech Stock to Watch for 2026